Chairman of the Board – Greig Woodring
Lead Director – James M. Benson
Board Member – William A. Roper
Chief Executive Officer – Tom Wamberg
Chief Science Officer – Dr. Tanya Moreno
Chief Medical Director – Dr. Philip Smalley
Chief Innovation Officer – Darren Rowe
Chief Financial Officer – Chad Stoerp
Director of Cancer Services – Irene Guterman
Managing Director – Bob Hebron
Managing Director – David Sterzer
Senior VP, Business Development – Lynnette Bates
Senior VP, Business Development – Erin Stalker
Executive VP, Sales & Business Development – Nick Bellanca
Director of Client Management – Tammy Kwok-Johnson
Regional Sales Director – Darrell Smith
A. Greig Woodring, Chairman
Greig Woodring is the retired President and Chief Executive Officer of Reinsurance Group of America, Incorporated (RGA). Prior to assuming the role of President and Chief Executive Officer of RGA in 1993, Greig served as Executive Vice President of General American Life Insurance Company (now GenAmerica Financial L.L.C.) in charge of all reinsurance business.
Greig joined General American in 1979 as an actuary, and assumed responsibility for General American’s reinsurance business in 1986. Before joining General American, he was an actuary at United Insurance Company in Chicago. General American’s reinsurance division led to the formation of RGA, which Greig led through its initial public offering in May 1993. After more than 20 years of his leadership, RGA grew to become one of the world’s leading life reinsurers, with offices in 26 countries and annual revenues of more than $10 billion.
Greig is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. He received a Bachelor of Science (B.S.) degree in mathematics from the University of Michigan, two years of post-graduate Mathematics study at the University of Illinois and an M.B.A. from Washington University in St. Louis. He also serves as Chairman of Wamberg Genomics Advisors, and as chairman of the International Insurance Society.
James M. Benson, Lead Director
James M. Benson currently serves as CEO of Benson Botsford, LLC. Jim has held CEO positions with John Hancock, Manulife, The New England, GenAmerica, and The Equitable Companies.
Mr. Benson earned a B.A. from the University of Illinois and an M.B.A. from the University of Southern California. He serves on several boards, including the United States Olympic Committee, University of Illinois Foundation and the Hospital for Special Surgery.
He is a Founder and Chairman of World T.E.A.M. Sports, an organization dedicated to providing opportunities through sports activities for the disabled.
William A. Roper, Board Member
Bill has significant leadership experience as chief executive officer, chief financial officer, and as a board member and investor in a number high growth companies over the past forty years. He has been involved in both publicly-owned and privately held enterprises involved in diversified technology services, biotechnology, and genomics products.
Bill also has broad experience in corporate mergers and acquisitions, public offerings of both debt and equity, international joint ventures, and numerous billion-dollar-plus financial transactions over the years.
Bill received his B.A. in Mathematics from the University of Mississippi, and he has completed advanced management programs at the Southwestern Graduate School of Banking at SMU and at Stanford University.
Tom Wamberg, Chief Executive Officer
Tom is the CEO of Wamberg Genomic Advisors and is responsible for the overall direction and execution of the company’s strategic plan. In his 30-year career, Wamberg has built and led numerous financial and professional insurance services businesses. In 2017 Wamberg served as President of Insurance and Corporate Business of Human Longevity, Inc. He served as Chairman of Uniphy Health, a secure healthcare collaboration platform for physicians, a company he co-founded in 2013. He previously started and led as Chairman and CEO two other consulting/brokerage companies, Clark & Wamberg, LLC and Clark Inc. (NYSE: CLK) which he took public in 1998. Wamberg is a member of the Association of Cancer Executives, the American Cancer Society CEOs Against Cancer, a member of the American College of Healthcare Executives, and is a past president of the Association for Advanced Life Underwriting.
He has also been past president of the 25 Million-Dollar Forum, chairman of the Legislative Task Force and Nonqualified Benefit Plan committee, and has served as a member of the American Society of Pension Actuaries and a member of the AALU’s Financial Accounting Standards Board subcommittee. Wamberg is also the author of three books: The Theory and Practice of Bank Owned Life Insurance, The Theory and Practice of Separate Account Bank Owned Life Insurance, and Bank Eligible Alternative Investment Strategies – The Theory and Practice. Tom also holds two patents: 1. System for designing and implementing Bank-Owned Life Insurance (BOLI) with a reinsurance option 2. Method and system for employee and client engagement.
He is a past board member of: The Universidad de las Americas (Mexico City), Students In Free Enterprise (SIFE), Integrated Healthcare Strategies, MEDEX, Baden Retirement Services, Stratford 360, Pearl Meyer & Partners, Stratford Advisory Services, and Wamberg Asset Management. He received his BS from Baldwin Wallace University and serves on the foundation board of the Cleveland Clinic.
Tom has testified before congressional committees on numerous occasions on behalf of the life insurance industry and as Chairman of Clark Consulting was a regular guest on CNBC, MSNBC and CNN as an expert on executive compensation and benefits. He is married to Cindy and they have eight children.
Tanya Moreno, PhD, MB(ASCP)CM, Chief Science Officer
Dr. Tanya Moreno is the Chief Science Officer of Wamberg Genomic Advisors. She is a senior executive scientific leader whose career interests are focused on applications of genetics and genomics in personalized medicine. With 15 years of experience in biotechnology and diagnostics, she has led the development and commercialization of a wide array of genomic tests for oncology, pharmacogenetics, rare disease disorders and infectious disease, creating advanced genomic tools to empower patients and physicians to make informed decisions based on their individual genetics.
As the head of Clinical Sciences, Research and Development in multiple clinical laboratories, she is a technical expert in use of advanced genomic technologies for precision medicine. Dr. Moreno is widely published in peer-reviewed journals and has both led and participated in a number of studies in consumer and clinical genomics research. She is an inventor of several novel genomic applications with multiple patents pending and granted. Dr. Moreno is passionate about science communication and broadening access and interest in STEAM for girls and women. She mentors young women and led a 3-year scientific curriculum for Big Brothers and Big Sisters of San Diego/Beyond School Walls.
Dr. Moreno received her bachelor’s degree in Chemistry at the University of California, San Diego. She earned her PhD in Biology focusing on genetic mechanisms of development at the California Institute of Technology in Pasadena, CA. Her post-doctoral studies on molecular controls of gene regulatory networks were performed at the Salk Institute for Biological Studies in San Diego, CA.
Dr. Philip Smalley, Chief Medical Director
Dr. Phil Smalley is an Internal Medicine specialist with 27 years of experience in insurance medicine. He recently retired from his position as Senior Vice President and Global Chief Medical Officer for RGA International Corporation. Dr. Smalley received his medical degree from the University of Toronto, Canada. He is a Fellow of the Royal College of Physicians and Surgeons of Canada and Past President of the Canadian Life Insurance Medical Officers Association.
Dr. Smalley was also Managing Director of the Longer Life Foundation, the not-for-profit research partnership between RGA and Washington University School of Medicine.
Dr. Smalley currently lives in Toronto consulting for the insurance industry and is Chief Medical Director for Wamberg Genomic Advisors.
Darren Rowe, Chief Innovation Officer
A co-founder and former CEO of the UK’s largest independent cancer navigation company, Darren is WGA’s Chief Innovation Officer, with leadership responsibility for strategic innovation and program design. Darren has a career background in the biotechnology, pharmaceutical and healthcare industries, and has held several leadership roles within companies specializing in the development of disruptive and innovative genomic technologies for personalized cancer treatments.
Leading Champions Oncology’s European subsidiary businesses, Darren helped them achieve a market cap of $180m from a zero base. Darren is a former board member of Bowel Cancer UK and current board member of UK-based health technology company Trustedoctor.
Whilst in the UK, Darren was a regular guest on the BBC, providing commentary on consumer-led healthcare issues. Darren studied Cognitive Behavioral Science at Leicester University in England and Executive Leadership and Organizational Innovation at Cornell Business School.
In his spare time, Darren mentors small businesses and designs programs to help individuals lead happier and more meaningful lives.
Darren and his family recently relocated to the USA from London, UK.
Chad Stoerp, Chief Financial Officer
As Chief Financial Officer of the company, Chad is responsible for the overall financial strategy at WGA, including funding, financial accounting and tax compliance.
Chad began his career as an auditor at BDO Seidman and has held various roles at Kemper Insurance, Essendant (formerly United Stationers), Clark & Wamberg, LLC and Uniphy Health. Chad has participated in sales, debt and equity transactions totaling over $125 million.
Chad holds a Bachelor of Business from Western Illinois University and is a Certified Public Accountant. He lives in Chicago with his wife, two daughters and two pugs.
Irene Guterman, MS, RN, CNL, Director of Cancer Services
Irene is the Director of Cancer Services for Wamberg Genomic Advisors, Inc. She is an experienced and innovative Oncology Nurse with over 10 years of experience working in the hospital and clinic settings with a background deeply rooted in research and evidence-based practice.
She began her career in the acute setting and found her home in Oncology, where she developed and led Survivorship and Mindfulness programs for a Comprehensive Cancer Center. Irene also has experience as a Facility Administrator and Team Leader for a Fortune 200 company. She is passionate about patient-centered care and empowering her patients to become active and informed participants throughout their cancer journey.
Irene is an avid yoga practitioner and instructor. She encourages her students to find balance both on and off the mat through a practice of intention setting, meditation, breath work, and physical postures.
She currently lives in San Diego with her husband and their four-legged child, Kooper.
Bob Hebron, JD, Managing Director
With a background in economics and law, Bob began his career as a trial lawyer, eventually moving to insurance counsel for litigation and emulators matters at Phoenix Mutual.
In 1988, Bob joined New York Life becoming its chief insurance counsel and taking responsibility for the defense of class action litigation related to the sale of life insurance in the 1990s. Following that stint he took over product development efforts for New York Life’s COLI and BOLI lines of business in 1996, growing that business from $3 billion in AUM to $20 billion plus in AUM.
He finished his career at New York Life responsible for third party distribution management in the life insurance line of business.
David Stertzer, Managing Director
David Stertzer is a Managing Director for Wamberg Genomic Advisors with a focus on life insurance companies and genomic / Advanced DNA Testing program strategies. As top officer at AALU for nearly thirty-three years, Stertzer provided continuity, leadership and strategic vision to AALU’s Board of Directors. Throughout the AALU’s growth period, David stressed the critical nature of a unified life insurance industry to deliver its message to Capitol Hill with a single voice and increase the number of successful members of the life insurance community.
Mr. Stertzer says, “The life insurance community has always innovated. New products and programs have consistently been created that have been critical components in meeting the comprehensive financial, and life needs of insureds. The programs being created by Wamberg are enabling the life insurance community and agents to be at the forefront of programs that extend and improve life. It is consistent with the values and purpose of life insurance. I am excited to be part of this mission to help the life insurance community and their agents make genomics and advanced DNA testing part of their portfolio.”
Lynnette Bates, Senior VP, Business Development
Lynnette is a Senior VP of Business Development for Wamberg Genomic Advisors, Inc., specializing in custom genomic-based product and service offerings for employee benefit brokers and insurance carriers.
Through Lynnette’s extensive background in Sales, Client Management, Marketing and Project Management she provides a strategic and holistic consulting approach for employers, insurance brokers and carriers. Previous companies include Human Longevity, Inc., Unum Insurance and American Express.
She graduated from Arizona State University in 2005 with a Bachelor of Arts in Mass Communications & Media Studies.
Erin Stalker, Senior VP, Business Development
Erin Stalker is a Senior VP of Business Development at Wamberg Genomic Advisors, Inc. She is responsible for the development and support of relationships within the insurance and employee benefits industry. In addition, she works with her team to develop custom genomic offerings for clients and prospects.
Before joining Wamberg Genomic Advisors she served as Senior Market Consultant within the Insurance and Corporate Business Department at Human Longevity, Inc. She educated and consulted members of the insurance community and large corporate businesses regarding genomics and Human Longevity, Inc.’s product portfolio.
She has over 10 years working within the insurance industry.
As a Senior Account Executive for a leading insurance carrier, she focused primarily on selling group and worksite benefits through her established relationships in Southern California. She also provided enrollment and technology recommendations and guidance to her brokers and clients.
Erin graduated with a degree in Applied Nutrition from California Polytechnic State University, San Luis Obispo in 2008, and currently lives with her husband Nick in San Diego, California.
Nick Bellanca, Executive VP, Sales & Business Development
Nick leads the growth and expansion of WGA’s group benefit division, focusing in on brokers, employers, carrier partners, and emerging distribution channels.
Prior to joining WGA, Nick was a top, national producer for a Fortune 500 insurance carrier for over 12 years. He partners closely with consultants, enrollment firms, benefits administration providers, and employers on the development and delivery of new and innovative employee benefit programs.
Nick holds a B.A. in Accounting from the University of San Diego.
Tammy Kwok-Johnson, Director of Client Management
Tammy Kwok-Johnson is the Director of Client Management for Wamberg Genomic Advisors, Inc. She is responsible for developing and overseeing client relationships and experience through proactive and personalized engagement, consultation and execution on custom, genomic-based, product and service offerings for employees.
Tammy has 15 years of experience in the insurance industry and has expertise in enrollment, benefits communication, group and worksite benefits. She previously worked in Human Resources and Accounting for a national nurse staffing agency and was an award-winning Senior Client Manager for a Fortune 500 benefits carrier.
She graduated from the University of California, San Diego in 2003 with a Bachelor of Arts in Psychology. Tammy also has an MBA with an emphasis in Human Resource Management.
Darrell Smith, Regional Sales Director
Darrell Smith has spent nearly 30 years in the Employee Benefits industry in both Sales and Sales Management positions throughout the Southeast. He has spent the past 24 years with a nationally recognized carrier, selling stop loss, ancillary lines, and voluntary benefits through brokers, consultants, and enrollment firms. He has experience in both the middle market (200 – 999 lives) and the large case space (1,000+). He has personally sold groups from as small as 50 employee lives to groups with over 150,000 employees.
Originally from New Orleans, Darrell has spent his entire career in the Employee Benefits industry and has sold various products including fully insured and self-funded medical, stop loss, dental, vision, life, disability, and voluntary/worksite products. He is an expert technician and is viewed as a trusted advisor by his brokers and consultants. He partners closely with brokers, consultants, enrollment firms, benefits administration providers, and employers to deliver innovative, genomic-based, employee benefit products that are beneficial to all parties.
He has past affiliations with ING/Voya, Reliance Standard, Washington National, and Met Life. Darrell holds a B.S. in Finance from Louisiana State University. He currently splits time between Tampa and Atlanta. Darrell is passionate about LSU football and enjoys salt-water fishing and attending live music festivals.